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Abstract: Little is known about the demographic characteristics of classic hallucinogen users and few investigations 
address the frequency of their use. This study used five years of data from The National Survey on Drug Use and 
Health, an annual, nationally representative, cross-sectional survey, conducted by the Substance Abuse and Mental 
Health Services Administration of the United States government, to examine age, gender, marital status, race/ethnicity, 
income, education, employment status and health status and among low, medium, and high frequency users of classic 
hallucinogens (N = 1323). Results indicated classic hallucinogen users were most likely to be White males between 18 
and 25 years old, who had never been married, had some college, were employed full-time, had a family income less 
than $20,000 per year, and were in very good health. High frequency hallucinogen users were more likely to be males in 
the “Other” racial/ethnic category who were less well educated, and less healthy, but they did not differ from other users 
in age, marital status, family income, or employment. Limitations and suggestions for future research are discussed. 
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The National Survey on Drug Use and Health 
(NSDUH) is an annual, nationally representative, cross-
sectional survey, conducted by the Substance Abuse 
and Mental Health Services Administration (SAMSHA) 
to gather data on drug use and health in the United 
States population. One section of the survey asks 
respondents about hallucinogen use, including LSD, 
phencylidine (PCP), mescaline, peyote, MDMA 
(Ecstasy), psilocybin, and a host of other drugs offered 
as possibilities to participants, including DMT, salvia 
divinorum, and ayahuasca. Participants are asked 
whether they have ever used any of these drugs and, if 
so, about the frequency of their use within the past 
year.  
The NSDUH, however, conflates several distinct 
drugs into the category of hallucinogens. Of those 
listed above, PCP and MDMA appear to have unique 
chemical structures, physiological effects, and use 
patterns compared to the classic hallucinogens (LSD, 
mescaline, peyote, and psilocybin). The classic 
hallucinogens, however, appear to form a more 
coherent category. Not only do they all act as agonists 
on serotonin 5-HT2 and 5-HT2A brain receptors [1-3], 
but they produce cross-tolerance with each other and 
the subjective effects are difficult for users to 
distinguish [4]. Thus, investigations focused on 
understanding correlates of hallucinogen use have 
frequently isolated classic hallucinogens from other 
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DEMOGRAPHICS 
Little is known about the demographic 
characteristics of classic hallucinogen users. Research 
into hallucinogen use was largely curtailed when the 
U.S. Congress enacted the Controlled Substances Act 
in 1970. Many economic, social, and political factors 
have fluctuated in the intervening decades, so early 
research may not accurately describe current 
hallucinogen users. For example, in the 1990’s Chilcoat 
and Schutz found that hallucinogen use often begins in 
late adolescence and is most prevalent among Whites 
with high family income [7], but more recently, Wu et al. 
[8] found that Asian-Americans, Native 
Hawaiians/Pacific Islanders, and mixed-race individuals 
have higher odds of hallucinogen use compared to 
Whites. Some recent research has also focused on 
hallucinogen use in dance clubs [9], whereas many 
early investigations focused on hallucinogen use on 
college campuses [10]. 
Frequency of Use 
Very few investigations address the frequency of 
hallucinogen use. Given that hallucinogens rapidly 
produce tolerance in animals and humans [4], 
frequency of hallucinogen use is likely to be low, but 
almost no attention has been paid to the frequency or 
quantity of hallucinogen use in the general population. 
One early study by Chunko [11] sampled 2,500 high 
school and college students who used LSD and found 
that 75.5% of current users reported using LSD from 
three to five times per month and 16.4% reported using 
it two or more times per week. However, there have 
been no similar studies in the last several decades. In 
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addition, poly-substance abuse and drug mixing 
complicate matters since these practices may be more 
common than single drug use, including among users 
of hallucinogens [12].  
The DSM-5 [13] focuses on functional impairment 
due to use to discriminate presence or absence of 
Other Hallucinogen Use Disorder, and drug use 
frequency is not currently one of the criteria. 
Furthermore, the status of classic hallucinogens as 
uniquely non-harmful and non-addictive has recently 
become a hotly debated issue. Nutt et al. [14, 15] have 
suggested that classic hallucinogens have a limited 
dependence potential and are among the least harmful 
of misused drugs. Results indicating that adolescent 
onset of hallucinogen use is not associated with 
symptoms of dependence, as it is with other classes of 
drugs [16], support this position. Likewise, 
hallucinogens are not known to cause compulsive use 
or harm to the brain or other body organs [4], and 
Rhesus monkeys self-administer hallucinogens 
sporadically, indicating they are only weakly reinforcing 
or have mixed reinforcing and aversive effects [17].  
Other researchers, however, have argued that 
higher quantity and frequency of consumption is 
associated with symptoms of dependence in 
hallucinogens as they are with other drug classes [18, 
19]. For example, age of first hallucinogen use may be 
related to the likelihood of developing dependence, 
although investigators disagree. Stone et al. [20] have 
found that early use increases the risk of hallucinogen 
dependence, whereas Chen, Storr and Anthony [16] 
found that early hallucinogen use is not associated with 
dependence as it is for most other drugs.  
In summary, few studies to date have investigated 
frequency of hallucinogen use in conjunction with other 
characteristics of users. Accordingly, the goal of this 
exploratory study was to examine the demographics 
characteristics and reported frequency of use of classic 
hallucinogen users in the NSDUH data. 
METHOD 
Five years of NSDUH data (2009-2013) were 
pooled for these analyses [21-25]. Participants in the 
current study were respondents with valid data on 
variables related to current classic hallucinogen use 
and relevant demographic variables. NSDUH 
interviewers met with individuals twelve years old and 
older in their homes to collect the data. Participants 
listened to prerecorded survey questions on 
headphones and provided responses on computers. 
More detailed information on NSDUH methodology is 
available at https://nsduhweb.rti.org/respweb/ 
homepage.cfm. The NSDUH survey was approved by 
the Institutional Review Board of the Research Triangle 
Institute and the current study was approved by the 
Institutional Review Board of Stockton University. 
Data Analysis 
Participants who had only ever used classic 
hallucinogens (LSD, peyote, mescaline, or psilocybin) 
were coded into a category indicating lifetime classic 
hallucinogen use. The NSDUH survey asks participants 
about their frequency of hallucinogen use during the 
past year, but it does not ask participants to identify 
which particular hallucinogen or combination of 
hallucinogens they used. Thus, in order to restrict 
results to those referring only to classic hallucinogen 
use, participants who had ever used PCP or Ecstasy 
were eliminated from the analyses.  
The NSDUH survey also asks participants if they 
have ever used other hallucinogens besides those 
already mentioned and includes a list of over one 
hundred possibilities, including drugs such as DMT, 
ayahuasca, ketamine, salvia divinorum, and others. 
Participants who affirmed that they had used other 
hallucinogens were also eliminated from further 
analyses in order to isolate cases reporting only 
frequency of classic hallucinogen use.  
Once participants who had ever used other 
hallucinogens besides LSD, peyote, mescaline or 
psilocybin were eliminated, they were then categorized 
according to their reported frequency of use of 
hallucinogens during the last year (HALYRTOT). Cases 
with valid data for frequency of use during the last 
twelve months were then coded into groups according 
to frequency of use: low (one to two times), medium 
(three to 23 times), or high (more than 23 times). 
Participants who had not used hallucinogens in the last 
year were eliminated from further analyses. 
Chi square tests were then used to assess the 
relative frequencies of the low, medium, and high 
frequency hallucinogen users with respect to the 
demographic variables of age, gender, marital status, 
race/ethnicity, income, education, employment status 
and health status. Post hoc z tests were performed with 
Bonferroni adjustments for p values to identify 
significant differences (p < .05) in use frequency within 
variable categories. Analyses were conducted using 
unweighted data due to the potential for distortion of 
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results by using relatively small sample to estimate 
population frequencies. 
RESULTS 
The data set contained a total of 244,385 cases, of 
which 32,983 (13.5%) reported ever having used any 
hallucinogen. Of those, 22,128 (67.1%) had ever used 
PCP, Ecstasy, or another hallucinogen besides LSD, 
peyote, mescaline or psilocybin, while 10,855 (32.9%) 
had only ever used classic hallucinogens. Of those 
participants who had only ever used classic 
hallucinogens, 9,322 (85.9%) had not used within the 
past year, leaving 1,323 classic hallucinogen users 
who reported use within the last year. 
The frequency of use during the last year 
(HALYRTOT) for this sample ranged from one to 260 
days. When they were broken into groups based on 
frequency of use, 893 (67.5%) had used one or two 
times, 319 (24.1%) had used three to 23 times, and 
111 (8.4%) had used more than 23 times during the 
past twelve months.  
Age 
Participants’ ages were collapsed into three 
categories to preserve the integrity of the chi square 
analysis. Three hundred sixty (27.2%) participants 
were 12-17 years old, 859 (64.9%) were 18-25, and 
104 (7.9%) were 26 or older. A chi square analysis 
indicated that frequency of hallucinogen use was not 
significantly associated with age, Χ2 (4, N = 1323) = 
7.14, p > .05, (see Figure 1). 
 
Figure 1: Ages of low, medium, and high frequency 
hallucinogen users (N = 1323). 
Gender 
Eight hundred ninety-eight (67.9%) of participants 
were male, and 425 (32.1%) were female. A chi square 
analysis indicated that frequency of hallucinogen use 
was significantly associated with gender, Χ2 (2, N = 
1323) = 6.83, p < .05. Compared to expected counts, 
males were significantly more likely to use with high 
frequency than medium or low frequency and 
significantly more likely to use with medium frequency 
than low frequency. Females were significantly more 
likely to use with low frequency than medium frequency 
and significantly more likely to use with medium 
frequency than high frequency (see Figure 2). 
With respect to their proportions within the 
frequency of use categories, males were significantly 
more likely than females to use with high frequency, 
(79.4% vs. 20.6% respectively; Χ2 (1, N = 97) = 5.653, 
p < .05), although observed proportions of gender did 
not differ within the low or medium frequency of use 
categories. 
 
Figure 2: Gender of low, medium, and high frequency 
hallucinogen users (N = 1323). 
Marital Status 
Participants were collapsed into two categories to 
preserve the integrity of the analysis. Eighty-five 
participants (6.7%) were married, separated or 
divorced, 1190 (93.3%) had never been married. A chi 
square analysis indicated that frequency of 
hallucinogen use was not significantly associated with 
marital status, Χ2 (2, N = 1275) = 4.87, p > .05, (see 
Figure 3). 
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Figure 3: Marital status of low, medium, and high frequency 
hallucinogen users (N = 1275). 
Race/Ethnicity 
Participants’ race/ethnicity was collapsed into three 
categories to preserve the integrity of the chi square 
analysis. There were 1013 White participants (76.7%), 
132 Hispanic participants (10.0%), and 178 participants 
in the Other category (13.5%; including Black/African 
American, Native American/Alaskan Native, Native 
Hawaiian/Pacific Islander, and mixed race). Results of 
the chi square indicated that frequency of hallucinogen 
use was significantly associated with race/ethnicity, Χ2 
(4, N = 1323) = 25.18, p < .001. Compared to expected 
counts, Whites were significantly more likely to use 
hallucinogens with low frequency than with medium or 
high frequency, and participants in the Other category 
were significantly more likely to use hallucinogens with 
medium or high frequency than with low frequency (see 
Figure 4). 
With respect to their proportions within the 
frequency of use categories, race/ethnicity was 
significantly associated with high frequency use (Χ2 (2, 
N = 97) = 13.647, p < .01), with Other participants most 
likely to use with high frequency. Race/ethnicity was 
also significantly associated with low frequency use (Χ2 
(2, N = 893) = 119.698, p < .001), with Whites most 
likely to use with low frequency. There were no 
significant differences in race/ethnicity within the 
medium frequency of use category. 
Income 
Four hundred thirty-five participants (32.9%) had a 
yearly family income of $20,000 or less, 390 (29.5%) 
earned $20,000 - $49,999, 162 (12.2%) earned 
$50,000 – $74,999, and 336 (25.4%) earned more than 
$75,000 per year. A chi square analysis indicated that 
frequency of hallucinogen use was not significantly 
associated with family income, Χ2 (6, N = 1323) = 6.44, 
p > .05, (see Figure 5). 
 
Figure 5: Income of low, medium, and high frequency 
hallucinogen users (N = 1323). 
Education 
One hundred thirty-three (10.1%) participants had 
less than a high school education, 308 (23.3%) were 
 
Figure 4: Race/ethnicity of low, medium, and high frequency 
hallucinogen users (N = 1323). 
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high school graduates, 382 (28.9%) had some college, 
140 (10.6%) were college graduates, and 360 (27.2%) 
were 12 to 17 years old. A chi square analysis 
indicated that frequency of hallucinogen use was 
significantly associated with education, Χ2 (8, N = 
1323) = 38.08, p < .001. Compared to expected counts, 
participants with less than a high school education 
were significantly less likely to use hallucinogens with 
low frequency than either medium or high frequency, 
and college graduates were significantly more likely to 
use hallucinogens with low frequency than medium or 
high frequency (see Figure 6). 
With respect to their proportions within the 
frequency of use categories, education was 
significantly associated with high frequency use (Χ2 (4, 
N = 97) = 16.47, p < .01), with participants with less 
than a high school education proportionately most likely 
to use with high frequency, and college graduates 
proportionately least likely to use with high frequency. 
There were no significant differences in education 
within the medium or low frequency of use categories. 
 
Figure 6: Education of low, medium, and high frequency 
hallucinogen users (N = 1323). 
Employment 
Participants aged 12 to 17 were eliminated from this 
analysis. Of the remaining participants, 360 (37.4%) 
were employed full time, 278 (28.9%) were employed 
part time, 135 (14.0%) were unemployed, and 190 
(19.7%) were not included in the labor force. A chi 
square analysis indicated that frequency of 
hallucinogen use was not significantly associated with 
employment status, Χ2 (6, N = 963) = 10.11, p > .05, 
(see Figure 7). 
 
Figure 7: Employment status of low, medium, and high 
frequency hallucinogen users (N = 963). 
Health 
Three hundred twenty-one participants (24.3%) 
reported being in excellent health, 611 (46.2%) 
reported very good health, 315 (23.8%) reported good 
health, and 76 (5.7%) reported fair or poor health. A chi 
square analysis indicated that frequency of 
hallucinogen use was significantly associated with 
health status, Χ2 (6, N = 1323) = 27.73, p < .001. 
 
Figure 8: Health of low, medium, and high frequency 
hallucinogen users (N = 1323). 
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Compared to expected counts, those reporting fair or 
poor health were significantly more likely to be high or 
medium frequency users than low frequency users (see 
Figure 8). 
With respect to their proportions within the 
frequency of use categories, health status was 
significantly associated with high frequency use (Χ2 (3, 
N = 97) = 22.83, p < .001), with participants in fair or 
poor health most likely to use with high frequency, and 
participants in excellent health least likely to use with 
high frequency. There were no significant differences in 
health status within the medium or low frequency of 
use categories. 
DISCUSSION 
These results provide a basis for generalizing about 
the demographic characteristics of classic hallucinogen 
users as well as drawing conclusions regarding the 
specific characteristics of those who use with varying 
frequency. In general, classic hallucinogen users were 
most likely to be White males between 18 and 25 years 
old, who had never been married, had some college, 
were employed full-time, had a family income less than 
$20,000 per year, and were in very good health. This 
description is consistent with research by Chilcoat and 
Schutz [7] that found that the highest proportion of 
hallucinogen users are young adults, but it contradicts 
findings from the same researchers that hallucinogen 
users were likely to have high income families. Finally, 
the relatively young age of users may contribute to the 
high proportion of users reporting that they were in very 
good health. 
Frequency of use did not vary significantly across 
age groups, but males were more likely to use with 
greater frequency than females, which may relate to 
risk-taking behavior generally. Marital status was also 
unrelated to frequency of use, but given the high 
proportion of users under 26 years old, it is not 
surprising that there were so few married, separated, or 
divorced participants in the sample. Family income also 
was not related to frequency of use, but users with less 
than a high school education were more likely to use 
hallucinogens more frequently and college graduates 
were more likely to use hallucinogens less frequently. 
Employment status was not associated with frequency 
of hallucinogen use, although the highest proportion of 
users were employed full time, which may imply that 
frequent hallucinogen use does not impair employment 
performance. However, high frequency users were 
more likely to report poor health than either low or 
medium frequency users.  
In summary, high frequency hallucinogen users 
were more likely to be males in the “Other” racial/ethnic 
category who were less well educated, and less 
healthy, but they did not differ from other users in age, 
marital status, family income, or employment. Although 
the sample for this research was too small to effectively 
investigate each racial/ethnic category, the high rate of 
high frequency use among the “Other” racial/ethnic 
category, which included Native Americans, is perhaps 
consistent with the high prevalence of peyote use 
among Native Americans [26].  
There are several limitations to this study, including 
the self-reported nature of the data. In particular, 
participants may have inaccurately recalled their 
frequency of hallucinogen use over the last year or 
inaccurately reported their health status due to the 
subjective nature of that evaluation. Another limitation 
is the cross-sectional nature of the NSDUH data, which 
prevents causal conclusions. Narrowing the sample to 
include users who have only ever used specific classic 
hallucinogens threatens the external validity of the 
findings since many classic hallucinogen users also 
use PCP, MDMA, and other hallucinogens as well. 
Another limitation of these findings is that the NSDUH 
data includes no information regarding the dose of 
hallucinogen taken by users, which may vary 
independent of use frequency.  
Despite these limitations, these results point toward 
important areas for future investigation. For example, 
future research should attempt to assess the 
personality characteristics, patterns of use, and 
motivation of frequent hallucinogen users compared to 
those who use less frequently. Qualitative 
investigations could be particularly useful in this effort. 
Future research should also follow up on these findings 
to investigate the reasons why higher levels of 
education may correlate with lower frequency of 
hallucinogen use and attempt to identify the mediators 
and moderators that influence the relationship between 
high frequency of use and poor health status. 
In general, it is hoped that this research may 
stimulate further work investigating the correlates of 
classic hallucinogen use and atypical patterns of use in 
order to promote a better understanding of the variety 
of people who use classic hallucinogens. 
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